The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking
Angela R. Harrison(Australian Regenerative Medicine Institute), Gregory W. Moseley(Australian Regenerative Medicine Institute)
Cited by 10
Related Papers
Lyssavirus P-protein selectively targets STAT3-STAT1 heterodimers to modulate cytokine signalling
|PLoS Pathogens|2020|27
Antagonism of STAT3 signalling by Ebola virus
|PLoS Pathogens|2021|16
Definition of mechanisms of viral protein multifunctionality reveals key roles of ‘conformer diversity’ and RNA interaction in forming host interfaces
|Research Square|2024|1
Antagonism of STAT3 signalling by Ebola virus
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0
The Ebola virus interferon antagonist VP24 undergoes active nucleocytoplasmic trafficking
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0